Condition 1: Pain. Condition 2: Sleep disorder. Condition 3: Fatigue. Other chronic pain Sleep disorders not due to a substance or known physiological condition Chronic fatigue, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults 18 to 64 years of age Reporting all three symptoms of pain, fatigue, and sleep disorder with at least two of the three rated = 4 in the last 24-hour Being currently on a chemotherapy regimen or have recently been on chemotherapy. Being at cancer stage I to IV
Exclusion criteria
Exclusion criteria: Platelet count less than 15,000 per cubic millimeter Existence of underlying diseases such as diabetes, peripheral neuropathy disease, etc. Skin disorders in massage area Known pain, fatigue and sleep disorders that are not caused by cancer and or its treatments Receiving any type of complementary medicine methods during the trial or within the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue intensity. Timepoint: Fatigue intensity will be measured before interventions. During the four weeks of interventions, the fatigue intensity will be measured at the end of each week of study. Also, during the four weeks of follow-up, the fatigue intensity will be measured at the end of each week. Totally, fatigue intensity will be measured for 9 times. Method of measurement: 0-10 Numeric Rating Scale.;Sleep disorder intensity. Timepoint: Sleep disorder intensity will be measured before interventions. During the four weeks of interventions, the sleep disorder intensity will be measured at the end of each week of study. Also, during the four weeks of follow-up, the sleep disorder intensity will be measured at the end of each week. Totally, sleep disorder intensity will be measured for 9 times. Method of measurement: 0-10 Numeric Rating Scale.;Intensity of symptom cluster of pain, fatigue and sleep disorder. Timepoint: Nine times from baseline to endpoint of follow-up. Method of measurement: Symptom cluster intensity will be measured using pain, fatigue, and sleep disturbance items. The mean scores of the three symptoms will be calculated as the symptom cluster intensity.;Pain intensity. Timepoint: Pain intensity will be measured before interventions. During the four weeks of interventions, the pain intensity will be measured at the end of each week of study. Also, during the four weeks of follow-up, the pain intensity will be measured at the end of each week. Totally, pain intensity will be measured for 9 times. Method of measurement: 0-10 Numeric Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesic received. Timepoint: Analgesic received will be measured before interventions. During the four weeks of interventions will be measured at the end of each week of study. Also, during the four weeks of follow-up will be measured at the end of each week. Totally, analgesic received will be measured for 9 times. Method of measurement: The analgesic received in the last 24 hours will be documented by the patient in the booklet. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences